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Abstract
Pregnancy in women with advanced liver disease is rare. In this paper we described the case of a
successful pregnancy in a young woman with advanced cirrhosis due to hepatitis B surface
antigenemia, hepatitis delta super-infection and Hepatitis C co-infection. A brief review of the
medical literature on pregnancy in women with cirrhosis is also presented.

Introduction
Pregnancy is uncommon in women with advanced cirrhosis and is associated with an increased risk of complications such as bleeding from esophageal varices, liver
failure, and hepatorenal syndrome [1-4]. Maternal deaths
have been reported in advanced cirrhosis mainly due to
variceal bleeding [4]. Spontaneous abortion and
increased risk of premature childbirth or stillbirth have
been reported in 15–20% of pregnancies in women with
cirrhosis [5]. We are reporting the case of a successful pregnancy outcome of a woman with decompensated cirrhosis, affected by hepatitis B, C and D viruses. To the best of
our knowledge this is the first report of pregnancy in a
mother who had combined hepatitis B antigenemia, hepatitis delta and hepatitis C infection.

Case report
A 32 year old mother of two children presented at 16
weeks gestation with abdominal distention and edematous legs. There was no history of hematemesis, melena or
altered mental status. Physical examination revealed pallor, spider telangectesia on the arms, palmer erythema
and pedal edema. Her abdominal examination showed

splenomegaly (to the level of the umbilicus) and moderate ascities. There was no clinical evidence of portosystemic encephalopathy. Her pulmonary, cardiovascular
and neurological examinations were unremarkable. Investigations revealed hemoglobin of 8.5 gm/dl with peripheral smear suggestive of microcytic hypochromic anemia,
total leukocyte count of 4200/mm3 (63% polymorphs
and 32% lymphocytes), platelets 40,000/mm3, total billirubin 2.0 mg/dl, serum glutamic oxaloacetic transaminase 74 (8–32) IU/L, serum glutamic pyruvic
transaminase 41 (Normal 3–33) IU/L, GGT of 61 IU/L
and alkaline phosphatase 81 (29–132) IU/L, serum albumin 2.3 gm/dl and prothrombin time 15.6 seconds (control 12 seconds). She had normal renal function and
electrolytes. Abdominal and pelvic ultrasound revealed a
shrunken liver, massive spleenomegaly, dilated portal
vein, moderate ascities (fig 1 &2) and a 16 week viable
fetus. Ascitic fluid analysis showed SAAG (serum ascitic
albumin gradient) of >1.1 without any evidence of spontaneous bacterial peritonitis. She had positive HBsAg,
HbeAb, HDV IgG, Anti-HCV antibody and HCV RNA in
her serum. However, HbeAg and HBV DNA were not
detected in her serum. Upper gastrointestinal endoscopy
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showed grade III esophageal varices (Fig 3) and severe
portal gastropathy but no gastric varices. Prophylactic
banding of esophageal varices was performed on two
occasions (at 17th and 23rd week of gestation). She was
given propranolol 10 mg trice a day and spiranolactone
200 mg daily. She underwent therapeutic paracentesis of
massive ascities at 28th week of gestation. Despite elaborate preparation for a planned vaginal delivery under controlled circumstances, the patient underwent an
unanticipated rapid labor and delivered a baby boy at a
local facility near her home during the 36th gestational
week.
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The patient and the baby did not have any complications
in the postpartum period. Her ascites was controlled with
diuretics. Surveillance endoscopy performed one year following delivery showed small esophageal varices and
mild portal gastropathy. The baby was given active and
passive immunization against hepatitis B. At the age of 18
months the baby's blood was tested for hepatitis B and C.
Serology showed undetectable Anti-HCV antibody and
Anti-HDV Ig-G. However, HBsAg was found to be positive
with normal ALT and undetectable HBV DNA.

Discussion
Infertility is common even in mild forms of chronic liver
diseases. Advanced cirrhosis increases the risk of maternal
and fetal morbidity and mortality [1,2]. In such cases the
stage of the liver disease is the most important determinant of the outcome of the pregnancy [1,2,6,7].
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In contrast to cirrhosis due to autoimmune etiology or
Alcoholic Liver Disease, the outcome of pregnancies in
women with other types of chronic liver disease, especially of viral etiology, is poorly reported and therefore
uncertain [8]. To date there has been no reported case
series related to the outcome of the pregnancy in patients
with decompensated cirrhosis due to viral etiology. Our
patient had had exposure to three hepatotropic viruses i.e.
HBV, HCV & HDV and had a successful outcome of pregnancy.
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Maternal death rate in women with cirrhosis is reported to
be 10.3% to 18% with massive gastrointestinal bleed as
the commonest cause of death [1,3] and liver failure as the
next most frequent cause of death [2]. In a review of 117
pregnancies a term pregnancy without maternal complications was achieved in 50% of cases while deterioration
in liver function tests was observed in 44.4% of cases.
Hematemesis occurred on 24 occasions and was responsible for maternal deaths in 4 % of patients [9].
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overall assessment of the severity of the liver disease as
well as of the patient's psychological status and desire for
children should lead logically to a resolution of these
issues on a case by case basis. With careful monitoring and
advanced management, successful pregnancy with a good
outcome is a good possibility. The excellent outcome of
the pregnancy in our patient is encouraging and supports
this opinion.
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There is an increased rate of spontaneous abortion, premature birth and perinatal deaths in pregnant woman
with advanced cirrhosis. Poor fetal prognosis is usually
explained by poor condition of the mother in decompensated patients. Though, infants born alive generally
remained well [2,3].

5.

In a controlled setting vaginal delivery is usually safe and
early forceps delivery or vacuum extraction should be considered to prevent any rise in portal pressure due to prolonged straining during labor [2,3]. Women with cirrhosis
generally tolerate laparotomy poorly; therefore the option
for caesarean section should be availed with care and caution. Our patient had an uncomplicated vaginal delivery
without any massive bleeding. She did not have further
hepatic decompensation, sepsis or any other complication. The baby boy had normal Apgar scores and birth
weight and had normal growth up to the end of follow up
at 18 months of age.
In short, the data related to the optimal management and
outcome of pregnancy in women with decompensated
cirrhosis secondary to viral etiology is limited. Whether to
advise a pregnancy to a woman with decompensated cirrhosis is a difficult question to answer. However, careful
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